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Multiple epidemiological studies concluded that lipoprotein lipase (LPL) function is 
inversely related to the incidence and severity of coronary artery disease. There is 
debate, however, because those seeking to identify the responsible mechanisms 
have reported higher than normal levels of LPL in the arteries of diseased mouse 
models. This confusion could be clarified by beginning to identify the LPL responses 
in pigs as a large animal model and determining the phenotypic effects of 
experimentally altering LPL on cultured endothelial cells and isolated vascular 
tissue. PURPOSE: We tested the hypothesis that LPL activity regulates the 
expression of thrombospondin-1 (TSP-1), eNOS, VCAM1, and the PPAR promoter 
activity in endothelial cells. METHODS: LPL activity and protein were measured in 
the plasma and heart of pigs fed a normal or high fat diet. The cellular effects of 
changing LPL activity were determined in primary porcine and human endothelial 
cells. Studies of VCAM1 were performed in cultured cells and isolated aortic 
segments. Northern and Western blots were used for mRNA and protein 
measurements, respectively. RESULTS: LPL-dependent lipolysis of VLDL suppressed 
TSP-1 expression several fold in endothelial cells (P 
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